Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
10X Genomics
Watchlist
10x Genomics: 바이오제약 분야에서 영향력을 확대하여 미래를 형성합니다!
Equity Bottom-Up
365 Views
27 Mar 2025 08:01
This page has been machine-translated. Click
here
to revert to original page
단일 세포 및 공간 전사체학의 선구자인 10x Genomics는 최근 4분기와 2024년 전체에 대한 재무 결과를 발표했습니다.
전체 통찰력에서 다루는 내용:
10x Genomics 소개
재무 결과 개요
제품 혁신 및 영향
평가 방법론
위험 및 기회 분석
요약
(접속하기 위해 가입하세요)
전체 통찰력
(유료 플랜만, 48-분 읽기)
관련 통찰력
More »
Loading
인기 컬렉션
More »
India
Index Rebalance
Event-Driven
Japan
South Korea
Equity Bottom-Up
China
Asia Event-Driven
Asia ECM
Sell / Short Ideas
트렌드 통찰력
More »
Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
Gold Miners ETF (GDX US): BIG Impact of Benchmark Change
SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too
Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer
Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
최고의 유료화되지 않은 통찰력
More »
Overview #27 – The Big Beautiful Tragi-Comedy Continues
HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
[IO Technicals 2025/24] Downward Momentum Lingers
China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
Bearishness Persist in Soybeans Despite Rebound Hopes
토론
(유료 플랜만)
가격 차트
(접속하기 위해 가입하세요)
인사이트 스트림
Loading...
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x